Latest News in Pharma industry12 hours agomRNA Vaccine Aftershocks Shake Pharma as Scientists Uncover Persistent Spike Protein and Investor Uncertainty Grows13 hours agoVariational AI Scores $5.5M to Disrupt Drug Discovery with Generative AI, Challenging Industry Giants13 hours agoPfizer Ends Beqvez Development as Gene Therapy Faces Market Reality1 day agoSolid Biosciences Stock Skyrockets as Gene Therapy Breakthrough Sparks Investor Frenzy2 days agoVIVOZON Secures MFDS Approval for UNAFRA Inj a Game Changer in Non Opioid Pain Relief5 days agoExelixis Shakes Up Kidney Cancer Treatment with Game-Changing Five-Year Data Proving CABOMETYX and Opdivo’s Lasting Survival Edge6 days agoZoetis Wins USDA Approval for H5N2 Avian Influenza Vaccine, Boosting Poultry Industry Hopes6 days agoAbbVie’s CEO Shake-Up: Robert A Michael Takes Over as Chairman Amid High-Stakes Industry Challenges7 days agoNexus Pharmaceuticals Wins FDA Approval for Tacrolimus Injection in Breakthrough Single-Dose Vial7 days agoFrom Stealth to $50 Million: How Latent Labs Is Using AI to Redesign Biology and Revolutionize Drug Discovery9 days agoJohnson & Johnson Reshapes MedTech with Billion-Dollar Stroke Care Exit10 days agoRegeneron’s Eylea HD Phase III Trial Success Signals Breakthrough in Macular Edema Treatment10 days agoTeva and Medincell Advance Schizophrenia Treatment with Successful Phase 3 Trial Completion11 days agoJapan Faces Vaccine Shortage Disrupting Immunization Plans and Market Stability13 days agoeGenesis Achieves Second Successful Pig Kidney Transplant in Major Xenotransplantation Breakthrough13 days agoBain Capital invests $3.3 billion in Japanese pharma firm with 300-year legacy14 days agoBioNTech’s Personalized Kidney Cancer Vaccine Shows Promise in Early Trial14 days agoEli Lilly’s 2025 Forecast Sparks Confidence as Weight-Loss Drugs Drive Growth14 days agoAriceum Secures FDA Orphan Drug Status for Cancer Therapy Amid Growing Radiopharmaceutical Race15 days agoQlaris Bio Advances Glaucoma Treatment with Promising Phase II Results16 days agoGenentech’s Susvimo Gains FDA Approval for Diabetic Macular Edema Pioneering a New Era in Eye Care16 days agoMAIA Biotechnology Advances THIO in Lung Cancer Treatment with Promising Phase II Results16 days agoAkribion Therapeutics Secures €8M to Advance Precision RNA-Guided Cell Depletion Technology16 days agoMITEM PHARMA Expands Rare Disease Portfolio with FLISINT Acquisition18 days agoMedian Technologies Advances AI Lung Cancer Screening with Key Regulatory Milestone20 days agoBristol Myers Squibb Moves Closer to EU Approval for Breyanzi in Follicular Lymphoma22 days agoAdvicenne Advances Cystinuria Treatment with FDA Nod, Paving Way for Faster Approval24 days agoEuropean Commission Approves New First-Line NSCLC Therapy with Superior Survival Benefits27 days agoIdentical Test Results Spark Serious Concerns About Chinese Generic Drug Quality27 days agoNovo Nordisk’s Amycretin Shows Promising Weight Loss Results in Early Trials28 days agoPurdue Pharma and Sacklers Agree to $7.4 Billion Opioid Settlement: A Landmark Deal That Redefines Corporate Accountability29 days agoZai Lab's Breakthrough: FDA Grants Orphan Drug Designation to Game-Changing SCLC Therapy ZL-131029 days agoBiogen Slashes 30-50% of Its 500-Person Research Team Amid Strategic Shift29 days agoSalubrisBio’s JK07 Shows Promising Steps Toward Heart Regeneration Amid Growing Hope and Challenges29 days agoArctic Therapeutics Secures €26.5M Series A to Transform Dementia Treatment Landscape30 days agoAmylyx Pharmaceuticals Breaks New Ground in ALS Treatment with FDA Approval to Advance AMX0114 Trial30 days agoBain Capital Targets $3.21B Acquisition of Mitsubishi Tanabe Pharma, Shaking Up Japan’s Pharma Sector30 days agoSolid Biosciences Secures FDA Fast Track for Groundbreaking Dual-Route Gene Therapy Targeting Friedreich’s Ataxia32 days agoFDA Approval of AstraZeneca's DATROWAY Brings Hope to Breast Cancer Patients but Faces Safety and Adoption Challenges34 days agoBoehringer Ingelheim's Schizophrenia Drug Trials Fail to Deliver, Shaking Up the Mental Health Treatment Landscape35 days agoScilex Expands Global Rights for Game-Changing Gout Treatment Gloperba®, Targets Booming $2B Market35 days agoOmeros Narsoplimab Breakthrough Drug Slashing Mortality in TA-TMA Patients Heads for FDA Approval36 days agoGilead Boosts Biotech Stake with 19.4% Ownership in HOOKIPA Pharma Amid Merger Talks38 days agoRevolutionizing Genetic Engineering: mvGPT Unveiled as a Game-Changing All-in-One Gene Therapy Tool38 days agoIncyte’s Ambitious 2025 Vision: Breakthrough Launches and Trials Amid Pipeline Challenges and Patent Expiry Pressures39 days agoJohnson & Johnson Eyes $14 Billion Deal to Acquire Biotech Star Intra-Cellular Therapies39 days agoRevolutionizing Healthcare: HHS Unveils Game-Changing AI Strategic Plan for Innovation, Equity, and Growth in 202540 days agoGilead Sciences and LEO Pharma Strike $1.7 Billion Deal to Revolutionize Anti-Inflammatory Treatments41 days agoEli Lilly Poised for $2.5 Billion Scorpion Therapeutics Acquisition to Revolutionize Cancer Treatment41 days agoFDA to Review Brexpiprazole-Sertraline Combo for PTSD: A Potential Game-Changer in Mental Health TreatmentLoad More
